Treatment of atrial fibrillation;Therapie von vorhofflimmern

Internist

Volumn 48, Issue 8, 2007, Pages 819-831

  Kirchhof, P ^a   Breithardt, G ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Antiarrhythmic drugs; Atrial fibrillation; Cardioversion; Catheter ablation; Drugs that regulate heart rate; Risk scores

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM ANTAGONIST; DIGITALIS; DIGITOXIN; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRONEDARONE; FLECAINIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IBUTILIDE; METOPROLOL; PHENPROCOUMON; PROPAFENONE; SOTALOL; VERAPAMIL; WARFARIN;

ATRIOVENTRICULAR CONDUCTION; CARDIOVERSION; CATHETER; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HUMAN; MORTALITY; PULMONARY VEIN; RECURRENT DISEASE; REVIEW; RISK; SINUS RHYTHM; STROKE; THROMBOEMBOLISM;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CATHETER ABLATION; COMBINED MODALITY THERAPY; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; ENDOMYOCARDIAL FIBROSIS; HEART ATRIA; HEART CONDUCTION SYSTEM; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; PLATELET AGGREGATION INHIBITORS; PULMONARY VEINS; RECURRENCE; STROKE; SURGERY, COMPUTER-ASSISTED; THROMBOEMBOLISM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34548523396     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-007-1899-5     Document Type: Review

References (24)

1. Go AS, Hylek EM, Phillips KA et al. (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285: 2370-2375
2. Fetsch T, Bauer P, Engberding R et al. (2004) Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial. Eur Heart J 25: 1385-1394
3. Heeringa J, Kuip DA van der, Hofman A et al. (2006) Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 27: 949-953
4. Lloyd-Jones DM, Wang TJ, Leip EP et al. (2004) Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 110: 1042-1046
5. Stewart S, Hart CL, Hole DJ et al. (2002) A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 113: 359-364
6. Patten M, Maas R, Bauer P et al. (2004) Suppression of paroxysmal atrial tachyarrhythmias - results of the SOPAT trial. Eur Heart J 25: 1395-1404
7. Fuster V, Ryden LE, Cannom DS et al. (2006) ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 8: 651-745
8. Page RL, Wilkinson WE, Clair WK et al. (1994) Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 89: 224-227
9. Jorgensen HS, Nakayama H, Reith J et al. (1996) Acute stroke with atrial fibrillation. The Copenhagen Stroke Study. Stroke 27: 1765-1769
10. Schotten U, Dobrev D, Kirchhof P et al. (2006) Vorhofflimmern: Grundlagenforschung liefert neue Therapieansätze. Dtsch Arztebl 103: A1743-A1748
11. Nieuwlaat R, Capucci A, Camm AJ et al. (2005) Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 26: 2422-2434
12. Wijffels MC, Kirchhof CJ, Dorland R et al. (1995) Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 92: 1954-1968
13. Albers GW (2004) Stroke prevention in atrial fibrillation: pooled analysis of SPORTIF III and V trials. Am J Manag Care 10: S462-S469; discussion S469-S473
14. Hylek EM, Go AS, Chang Y et al. (2003) Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 349: 1019-1026
15. Wang TJ, Massaro JM, Levy D et al. (2003) A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA 290: 1049-1056
16. Corley SD, Epstein AE, DiMarco JP et al. (2004) Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 109: 1509-1513
17. Testa L, Biondi-Zoccai GG, Dello Russo A et al. (2005) Rate-control vs. rhythm-control in patients with atrial fibrillation: a meta-analysis. Eur Heart J 26: 2000-2006
18. Alboni P, Botto GL, Baldi N et al. (2004) Outpatient treatment of recent-onset atrial fibrillation with the.,pill-in-the-pocket" approach. N Engl J Med 351: 2384-2391
19. Lafuente-Lafuente C, Mouly S, Longas-Tejero MA et al. (2006) Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials. Arch Intern Med 166: 719-728
20. Healey JS, Baranchuk A, Crystal E et al. (2005) Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol 45: 1832-1839
21. Cox JL (2004) Cardiac surgery for arrhythmias. Pacing Clin Electrophysiol 27: 266-282
22. Fisher JD, Spinelli MA, Mookherjee D et al. (2006) Atrial fibrillation ablation: reaching the mainstream. Pacing Clin Electrophysiol 29: 523-537
23. Kirchhof P, Fetsch T, Hanrath P et al. (2005) Targeted pharmacological reversal of electrical remodeling after cardioversion-rationale and design of the Flecainide Short-Long (Flec-SL) trial. Am Heart J 150: 899
24. Kirchhof P, Mönnig G, Wasmer K et al. (2005) A trial of self-adhesive patch electrodes and hand-held paddle electrodes for external cardioversion of atrial fibrillation (MOBIPAPA). Eur Heart J 26: 1292-1297